Skip to main content
Published Online:https://doi.org/10.1024/0939-5911.a000386

Zusammenfassung.Zielsetzung: Die Pathogenese der Komorbidität der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) und Substanzabhängigkeit hat große klinische Relevanz, da nach klinisch-epidemiologischer Erfahrung bei ADHS-Patienten einerseits häufig eine komorbide Substanzabhängigkeit vorliegt, andererseits sich daraus erhebliche Konsequenzen für das therapeutische und diagnostische Procedere ergeben. Zusammenhänge von ADHS und Substanzstörungen: Neben der „Dopaminmangelhypothese“ bei ADHS sind unter anderem das Konzept des „Sensation-Seekings“ (Zuckerman, 1979) und die „Selbstmedikations-Hypothese“ (Khantzian, 1985) auch im Zusammenhang mit anderen komorbiden Störungen von Belang. Schlussfolgerungen für die Praxis: Die Diagnostik von ADHS-Patienten sollte Substanzstörungen und andere psychische Komorbiditäten berücksichtigen. Klinische Implikationen für die Pharmakotherapie lassen sich insbesondere aus der „Dopaminmangelhypothese“ und den beobachteten depressiven Symptomen bei ADHS-Patienten ableiten: neben der möglichen Behandlung mit Methylphenidat wird daher vorgeschlagen, den therapeutischen Wert von selektiven Dopamin- oder Noradrenalin-Wiederaufnahme-Hemmern und darüber hinaus insbesondere auch psychotherapeutische Behandlungsverfahren zu nutzen.


Pathogenesis of the Comorbidity of ADHD and Substance Use Disorders – A Clinical Perspective and Implications for Pharmacotherapy

Abstract.Aim: An understanding of the pathogenesis of the comorbidity of attention deficit/hyperactivity disorder (ADHD) and substance use disorders is clinically relevant. According to clinical-epidemiological expertise, ADHD patients often show a comorbid substance dependence, resulting in significant consequences for therapeutic and diagnostic procedures. Relationship of ADHD and substance use disorders: In addition to the “dopamine-deficiency hypothesis” for ADHD, the concept of “sensation-seeking” (Zuckerman, 1979) and the “self-medication hypothesis” (Khantzian, 1985) are relevant for understanding the comorbidity of ADHD and substance use disorders. Clinical implications: Diagnostic routines of ADHD patients should consider substance use disorders and other psychiatric comorbidities. The “dopamine-deficiency hypothesis” and the observed depressive symptoms in ADHD patients support clinical pharmacological implications: Besides the possible treatment with methylphenidate the therapeutic value of substances such as SSRI and SNRI should be considered – as well as a psychotherapy.

Literatur

  • Asherson, P., Brookes, K., Franke, B., Chen, W., Gill, M. & Ebstein, R. P., et al. (2007). Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined–type ADHD. American Journal of Psychiatry, 164, 674 – 677. First citation in articleCrossrefGoogle Scholar

  • Biederman, J., Wilens, T., Mick, E., Milberger, S., Spencer, T. J. & Faraone, S. V. (1995). Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. American Journal of Psychiatry, 152, 1652 – 1658. First citation in articleCrossrefGoogle Scholar

  • Biederman, J., Wilens, T. E., Mick, E., Faraone, S. V. & Spencer, T. (1998). Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biological Psychiatry, 44, 269 – 273. First citation in articleCrossrefGoogle Scholar

  • Carroll, K. M. & Rounsaville, B. J. (1993). History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Comprehensive Psychiatry, 34, 75 – 82. First citation in articleCrossrefGoogle Scholar

  • Cloninger, C. R. (1986). A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatric Developments, 4, 167 – 226. First citation in articleGoogle Scholar

  • Conners, C. K., Levin, E. D., Sparrow, E., Hinton, S. C., Erhardt, D., & Meck et al. (1996). Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). Psychopharmacological Bulletin, 32, 67 – 73. First citation in articleGoogle Scholar

  • Donfrancesco, R., Di Trani, M., Porfirio, M. C., Giana, G., Miano, S. & Andriola, E. (2015). Might the temperament be a bias in clinical study on attention-deficit hyperactivity disorder (ADHD)? Novelty Seeking dimension as a core feature of ADHD. Psychiatry Research, 227, 333 – 338. First citation in articleCrossrefGoogle Scholar

  • Dougherty, D. D., Bonab, A. A., Spencer, T. J., Rauch, S. L., Madras, B. K. & Fischman, A. J. (1999). Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet, 354, 2132 – 2133. First citation in articleCrossrefGoogle Scholar

  • Dresel, S., Krause, J., Krause, K. H., LaFougere, C., Brinkbaumer, K., & Kung K. et al. (2000). Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. European Journal of Nuclear Medicine, 27, 1518 – 1524. First citation in articleCrossrefGoogle Scholar

  • Ernst, M., Zametkin, A. J., Matochik, J. A., Jons, P. H. & Cohen, R. M. (1998). DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18] fluorodopa positron emission tomographic study. The Journal of Neuroscience, 18, 5901 – 5907. First citation in articleCrossrefGoogle Scholar

  • Hahesy, A. L., Wilens, T. E., Biederman, J., Van Patten, S. L. & Spencer, T. (2002). Temporal association between childhood psychopathology and substance use disorders: findings from a sample of adults with opioid or alcohol dependency. Psychiatry Research, 109, 245 – 253. First citation in articleCrossrefGoogle Scholar

  • Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., & Demler, O. et al. (2006). The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. American Journal of Psychiatry, 163, 716 – 723. First citation in articleCrossrefGoogle Scholar

  • Khantzian, E. J. (1983). An extreme case of cocaine dependence and marked improvement with methylphenidate treatment. American Journal of Psychiatry, 140, 784 – 785. First citation in articleCrossrefGoogle Scholar

  • Khantzian, E. J. (1985). The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. American Journal of Psychiatry, 142, 1259 – 1264. First citation in articleCrossrefGoogle Scholar

  • Kooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M. & Carpentier, P. J., et al. (2010). European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry, 10, 67. First citation in articleCrossrefGoogle Scholar

  • Krause, J., Biermann, N. & Krause, K. H. (2002). Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Alkoholikern. Nervenheilkunde, 21, 156 – 159. First citation in articleGoogle Scholar

  • Krause, K. H., Dresel, S. H., Krause, J., Kung, H. F., Tatsch, K. & Ackenheil, M. (2002). Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder. International Journal of Neuropsychopharmacology, 5, 111 – 113. First citation in articleCrossrefGoogle Scholar

  • Levin, E. D., Conners, C. K., Sparrow, E., Hinton, S. C., Erhardt, D., & Meck, W. H. et al. (1996). Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berlin), 123, 55 – 63. First citation in articleCrossrefGoogle Scholar

  • Levin, F. R. & Kleber, H. D. (1995). Attention-deficit hyperactivity disorder and substance abuse: relationships and implications for treatment. Harvard Review of Psychiatry, 2, 246 – 258. First citation in articleCrossrefGoogle Scholar

  • Mannuzza, S., Klein, R. G., Bessler, A., Malloy, P. & LaPadula, M. (1993). Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Archives of General Psychiatry, 50, 565 – 576. First citation in articleCrossrefGoogle Scholar

  • Mannuzza S., Klein R. G. & Moulton J. L. (2008). Lifetime criminality among boys with attention deficit hyperactivity disorder: a prospective follow-up study into adulthood using official arrest records. Psychiatry Research, 160, 237 – 246. First citation in articleCrossrefGoogle Scholar

  • Modestin, J., Matutat, B. & Würmle, O. (2001). Antecedents of opioid dependence and personality disorder: Attention-deficit/hyperactivity disorder and conduct disorder. European Archives of Psychiatry and Clinical Neuroscience, 251, 42 – 47. First citation in articleCrossrefGoogle Scholar

  • Ohlmeier, M. D., Peters, K., Kordon, A., Seifert, J., Wildt, B. T. & Wiese, B., et al. (2007). Nicotine and alcohol dependence in patients with comorbid attention-deficit/hyperactivity disorder (ADHD). Alcohol and Alcoholism, 42, 539 – 543. First citation in articleCrossrefGoogle Scholar

  • Ohlmeier, M. D., Peters, K., Te Wildt, B. T., Zedler, M., Ziegenbein, M., Wiese, B., Emrich, H. M. & Schneider, U. (2008). Comorbidity of alcohol and substance dependence with attention-deficit/hyperactivity disorder (ADHD). Alcohol and Alcoholism, 43, 300 – 304. First citation in articleCrossrefGoogle Scholar

  • Ohlmeier, M. D., Roy, M., Dillo, W. & Prox-Vagedes, V. (2010). ADHS und Abhängigkeitserkrankungen. Persönlichkeitsstörungen, 14, 48 – 60. First citation in articleGoogle Scholar

  • Pontieri, F. E., Tanda, G., Orzi, F. & Di Chiara, G. (1996). Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature, 382, 255 – 257. First citation in articleCrossrefGoogle Scholar

  • Rasmussen, P. & Gillberg, C. (2000). Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study. Journal of the American Academy of Child & Adolescent Psychiatry, 39, 1424 – 1431. First citation in articleCrossrefGoogle Scholar

  • Rosler, M., Retz, W., Retz-Junginger, P., Hengesch, G., Schneider, M. & Supprian, T., et al. (2004). Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates. European Archives of Psychiatry and Clinical Neuroscience, 254, 365 – 371. First citation in articleGoogle Scholar

  • Salgado, C. A., Bau, C. H., Grevet, E. H., Fischer, A. G., Victor, M. M. & Kalil, K. L., et al. (2009). Inattention and hyperactivity dimensions of ADHD are associated with different personality profiles. Psychopathology, 42, 108 – 112. First citation in articleCrossrefGoogle Scholar

  • Schmidt, S., Brücher, K. & Petermann, F. (2006). Komorbidität der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung im Erwachsenenalter: Perspektiven für die Diagnostik mit dem BAS-E. Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 54, 123 – 132. First citation in articleLinkGoogle Scholar

  • Schubiner, H., Tzelepis, A., Milberger, S., Lockhart, N., Kruger, M. & Kelley, B. J., et al. (2000). Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. Journal of Clinical Psychiatry, 61, 244 – 251. First citation in articleCrossrefGoogle Scholar

  • Sizoo, B., van den Brink, W., van Eenige, M. G. & van der Gaag, R. J. (2009). Personality characteristics of adults with autism spectrum disorders or attention deficit hyperactivity disorder with and without substance use disorders. The Journal of Nervous and Mental Disease, 197, 450 – 454. First citation in articleCrossrefGoogle Scholar

  • Spencer, T., Biederman, J., Wilens, T., Prince J., Hatch & M., Jones J., et al. (1998). Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. American Journal of Psychiatry, 155, 693 – 695. First citation in articleCrossrefGoogle Scholar

  • Sullivan, M. A. & Rudnik-Levin, F. (2001). Attention deficit/hyperactivity disorder and substance abuse. Diagnostic and therapeutic considerations. Annals of the New York Academy of Sciences, 931, 251 – 270. First citation in articleCrossrefGoogle Scholar

  • Swanson, J.M. & Volkow, N.D. (2009): Psychopharmacology: concepts and opinions about the use of stimulant medications. Journal of Child Psychology and Psychiatry, 50, 180 – 93. First citation in articleCrossrefGoogle Scholar

  • Tarter, R. E., Kirisci, L., Feske, U. & Vanyukov, M. (2007). Modeling the pathways linking childhood hyperactivity and substance use disorder in young adulthood. Psychology of Addictive Behaviors, 21, 266 – 271. First citation in articleCrossrefGoogle Scholar

  • Upadhyaya, H. P. (2007). Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder. Journal of Clinical Psychiatry, 68 Suppl 11, 23 – 30. First citation in articleCrossrefGoogle Scholar

  • Upadhyaya, H. P., Brady, K. T. & Wang, W. (2004). Bupropion SR in adolescents with comorbid ADHD and nicotine dependence: a pilot study. Journal of the American Academy of Child & Adolescent Psychiatry, 43, 199 – 205. First citation in articleCrossrefGoogle Scholar

  • Upadhyaya H. P., Brady K. T., Sethuraman G., Sonne S. C. & Malcolm R. J. (2001). Venlafaxine Treatment of Patients With Comorbid Alcohol/Cocaine Abuse and Attention-Deficit/Hyperactivity Disorder: A Pilot Study. Journal of Clinical Psychopharmcology, 21, 116 – 118. First citation in articleCrossrefGoogle Scholar

  • Volkow, N. D., Wang, G. J., Ma Y., Fowler, J. S., Zhu, W., & Maynard, L. et al. (2003). Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. Journal of Neurosciences, 23, 11461 – 11468. First citation in articleGoogle Scholar

  • Young S., Gudjonsson G., Wells J., Asherson P. & Theobald J., Oliver B., et al. (2009). Attention deficit hyperactivity disorder and critical incidents in a Scottish prison population. Personality and Individual Differences, 46, 265 – 269. First citation in articleCrossrefGoogle Scholar

  • Wilens, T. E. (2004). Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatric Clinics of North America, 27, 283 – 301. First citation in articleCrossrefGoogle Scholar

  • Wilens, T. E., Adler, L. A., Weiss, M. D., Michelson, D., Ramsey, J. L. & Moore, R. J., et al. (2008). Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug and Alcohol Dependence, 96, 145 – 154. First citation in articleCrossrefGoogle Scholar

  • Wilens, T. E., Biederman, J., Mick, E., Faraone, S. V. & Spencer, T. (1997). Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. Journal of Nervous and Mental Disease, 185, 475 – 482. First citation in articleCrossrefGoogle Scholar

  • Wilens, T. E., Hahesy, A. L., Biederman, J., Bredin, E., Tanguay, S. & Kwon, A., et al. (2005). Influence of parental SUD and ADHD on ADHD in their offspring: preliminary results from a pilot-controlled family study. American Journal of Addiction, 14, 179 – 187. First citation in articleCrossrefGoogle Scholar

  • Zuckerman, M. (1979). Sensation Seeking: beyond the optimal level of arousal. Hillsdale/NJ: Lawrence Erlbaum. First citation in articleGoogle Scholar